Lowenstein Sandler represented Coya Therapeutics in the transaction.Coya Therapeutics (NASDAQ: COYA), a clinical-stage biotechnology company, announced a development-and-license deal with Dr. Reddy’s Laboratories for its COYA…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now